BBVA
RNTX

Banco Bilbao Vizcaya Argentaria’s Rein Therapeutics RNTX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-42,713
Closed -$1.01M – 770
2020
Q2 		$1.01M Buy
42,713
+20,000
+88% +$326K 0.03% 401
2020
Q1 		$150K Buy
22,713
+17,713
+354% +$213K 0.01% 639
2019
Q4 		$57K Buy
+5,000
New +$49.3K ﹤0.01% 710

Other funds holding RNTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's RNTX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Rein Therapeutics (RNTX) in Q3 2020, closing a stake of 42,713 shares — an estimated $1.01M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in RNTX in Q4 2019 and held it in 3 quarters. The position peaked at $1.01M in Q2 2020. 28 funds tracked by Wall St. Rank hold RNTX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Rein Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 42,713 Rein Therapeutics shares in Q3 2020, an estimated $1.01M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Rein Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Rein Therapeutics position peaked at $1.01M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.